Acquiring Company
Swiss Rockets AG
Acquired Company
Complete Genomics
San JoseBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareGeneticsLife ScienceDescription
Complete Genomics has confirmed it has entered into a definitive agreement to be acquired by Swiss Rockets AG. The acquisition is expected to enhance Complete Genomics' innovation pipeline and manufacturing capacity. Upon closing, Swiss Rockets will own 100% of Complete Genomics, which will continue operations under its current management team.
Quick answer
Swiss Rockets AG is acquiring Complete Genomics, announced February 23, 2026.
- How much did Swiss Rockets AG pay for Complete Genomics?
- The deal value was not disclosed.
- What does Swiss Rockets AG do?
- Swiss Rockets AG is a biotechnology company focused on developing innovative cancer therapies using cutting-edge radioisotope technologies.
- Where are Swiss Rockets AG and Complete Genomics based?
- Complete Genomics is based in San Jose, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Genetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cyclerion to merge with Korsana Biosciences (April 1, 2026)
- Aurinia acquires Kezar Life Sciences for $6.955/share (March 30, 2026)
- Gilead to acquire Ouro Medicines for $2 billion, $2B (March 23, 2026)
- GLAUKOS Corp acquires Mobius Therapeutics for $12.4M, $12M (February 23, 2026)
- Sensei Biotherapeutics acquires Faeth Therapeutics (February 18, 2026)
- AbbVie to acquire Revolution Medicines soon (January 9, 2026)
Who to call at Swiss Rockets AG, and when
When Swiss Rockets AG changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Swiss Rockets AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Swiss Rockets AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Swiss Rockets AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Swiss Rockets AG makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Complete Genomics?
Complete Genomics was acquired by Swiss Rockets AG. The deal was reported on February 23, 2026. Swiss Rockets AG is a biotechnology company focused on developing innovative cancer therapies using cutting-edge radioisotope technologies. Swiss Rockets AG is privately held and operates in Biotechnology.
When did Swiss Rockets AG acquire Complete Genomics?
Swiss Rockets AG's acquisition of Complete Genomics was reported on February 23, 2026. Complete Genomics has confirmed it has entered into a definitive agreement to be acquired by Swiss Rockets AG. The acquisition is expected to enhance Complete Genomics' innovation pipeline and manufacturing capacity. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Complete Genomics do?
Complete Genomics is a pioneering life sciences company that provides novel, end to end DNA sequencing solutions. It has been at the forefront of high throughput sequencing technology development since its inception in 2005. It is privately held, operating in Biotechnology, and is based in San Jose.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.